{"name":"Liu Huang","slug":"liu-huang","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOVGFYTVJzS2x0MThmc1ZwOWdxMEtfOGxZOUEwWWhRSU9yRlFpdlQxek1DalRwX0trNkRQYWd5cWZVRUllbUN4YzB1QU1udFRHSDdELVdZM2dsRDd2SXc0M0hXMGZGeV82LUhIRjhIYnRfVXNwNDV5TDVuNlN2QjRqajdnUkpQYmo0X3AybTNnWnZGVWMzczZ4WjBkTWNoTHJYR3EwTVFJelhjdw?oc=5","date":"2026-03-19","type":"pipeline","source":"News-Medical","summary":"ADC efficacy and safety evaluation using advanced organoid models - News-Medical","headline":"ADC efficacy and safety evaluation using advanced organoid models - News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTFBrNFhiOXVaT0hDdE9ET2ZLRmx3ZEZYdDhIbHNqRUh6a2V0N3RpaERPRVhlczNHU0RaZzU4YkVWTm9kODFOamlpOFNzY3BDRGZpU0F5TGpOODM2X29uR1d5dHZZUW42NEYwQ0J2WUN4UC1wX1NZaXhDLTdR?oc=5","date":"2026-01-14","type":"pipeline","source":"Fierce Pharma","summary":"JPM26, Day 3: AbbVie touts 'clear line of sight' to continued growth into 2030s - Fierce Pharma","headline":"JPM26, Day 3: AbbVie touts 'clear line of sight' to continued growth into 2030s","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQeUZEUGhSb0daR1FMTnNQbnhaX2M4V0RxUi1IZUlDZUJPMGpRbVVSekxlMnNxNUNYYmpWd1F3MUFaU2ljRlBwbVRyN01JeDB3Nk9KcEI2SlpyWkt1OTRaTDlxT0Q5andDVmM3bkg4UlZkTWJhTWdLRzhQeFNNbUV2aEh4TE1FdGpRc0N6MkJRMWZ1bWVPbTNyRnFyX1pNbEFxS2c?oc=5","date":"2025-10-02","type":"deal","source":"Fierce Biotech","summary":"Novo vs. KBP: How a $1.3B deal turned into a fraud accusation and an international legal fight - Fierce Biotech","headline":"Novo vs. KBP: How a $1.3B deal turned into a fraud accusation and an international legal fight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4zd2YtYkpQaV9pS3UxaTVRLXpKSmpOTmsySjdmU29SdkZlRDZJNHU1c2JueDI5anBDT0VSYzZYSEVUNEVyS3pyOG9ZeW5zOXM4bE11TUEtd3ZLMnlsS0lV?oc=5","date":"2025-09-23","type":"pipeline","source":"Nature","summary":"A collaborative large language model for drug analysis - Nature","headline":"A collaborative large language model for drug analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTFBlRTZKNTVqNDdBbkU4bkxrdlBfNlJWYmc1Z3dxZzlYU21YV05Pa1dlNldGbDBDS0p0WnJucDlhM1ZkNldWaWFONmVxT2V2TFRWUm5nNEN1QWR4MW5sdFJyVDBUTGptbW9heFE?oc=5","date":"2025-06-03","type":"pipeline","source":"Wiley Online Library","summary":"Elevation of ISG15 promotes diabetic kidney disease by modulating renal tubular epithelial cell pyroptosis - Wiley Online Library","headline":"Elevation of ISG15 promotes diabetic kidney disease by modulating renal tubular epithelial cell pyroptosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1Qam9mVFZtMGVoNXIxaldmQ2RtajF3Zkw1TzVHa0RpMHNIZ3M5WC1KdzAtMVBPUGpCUDcxZ2x2c08wb3NKRDFyUURMeXRVOGgzdFVDX01SUmpoam5pTENR?oc=5","date":"2025-05-16","type":"pipeline","source":"Nature","summary":"Research on operation strategy of multiple channels pharmaceutical supply chain based on blockchain technology - Nature","headline":"Research on operation strategy of multiple channels pharmaceutical supply chain based on blockchain technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1IY0dlNnp0RlBid0dfN083WTFtWWtsa0NiR2pZR3hiTHpJXzdJYi1HV2drRzJnM0hmcVRibEtXajN6STZQZ0p0TF9HOHVwMFhoVWx1TEZIaWNNWVMyN0w1ak95U0hDUXc?oc=5","date":"2025-05-09","type":"pipeline","source":"Fierce Pharma","summary":"Angela Hwang on her pivot from Big Pharma to biotech - Fierce Pharma","headline":"Angela Hwang on her pivot from Big Pharma to biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPVklLclludjRkWW5HbTFVRktrUVN0d21PRlB4SG1xR0FkaEE5UWl4SzZOSnZuRDF5TE9oWXJMNkNlVlhsd3JQck9iZzR6b3FIV2NpSDFrMjN3bG90bVVwTkNEQzdwTjdYYUJDWVNObjR2RGJWRXBpVU1JenlqRjlqLXgxU2hkREg3SVhuVVVzNjVDay1Cb1FWb0hrcTlCQm5BSVE?oc=5","date":"2025-02-21","type":"regulatory","source":"Fierce Pharma","summary":"Fierce Pharma Asia—Novo Nordisk's fraud accusation; AstraZeneca's China deal; Ono's FDA nod - Fierce Pharma","headline":"Fierce Pharma Asia—Novo Nordisk's fraud accusation; AstraZeneca's China deal; Ono's FDA nod","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFBOdlB0VVpKNmVwdjZtSGdyUmFjRGJMUWpHQUxqTFdNa1E2aTZDbDhMOE9zX3hDQV9IeWNWbFFwelpaUnU1QXBhS2s3dWhtWWhQOUJjeHlxZGVuMTJKRkwyS0VxeThLX2Q4Y3Y0Ti1mOA?oc=5","date":"2024-11-27","type":"pipeline","source":"Wiley Online Library","summary":"Visible Light‐Mediated [4+2] Annulation of Silylimines with Olefins to 1‐Aminotetralins Enabled by Diradical Hydrogen Atom Transfer of C−H Bonds - Liu - 2025 - Angewandte Chemie International Edition ","headline":"Visible Light‐Mediated [4+2] Annulation of Silylimines with Olefins to 1‐Aminotetralins Enabled by Diradical Hydrogen At","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOdXV3N3pILUh0b0dwc1ZVQWRNb2ZYVkZ3ejQ0Vnh6ZXcxdExhbE1TZXk2U3N1aGdxT3VadUZkeGFxLUgtcENaUUpvS2NQdWo0Z25QYlhPVWNPV3ZYM2VjdmgwVkN3Y2tjTFJKNUJhVThIaFZ5cWY2ZDRtVGFvQ2FSRE1SM0FmN3RJb2ctQzlNS0c?oc=5","date":"2024-06-14","type":"pipeline","source":"ScienceDirect.com","summary":"Journal of Pharmaceutical Analysis - ScienceDirect.com","headline":"Journal of Pharmaceutical Analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBmYzdHUDdSMmlaQ3FydGVhRFJlVTY4dTU1YXVwaVJuU2lKVGwzWXVjSFNGckdZaUlrSXppdVJwVmk3UTJzd0hka3JxY0lJUXdWd3lxZ2FvdWNEeHdwNG5J?oc=5","date":"2023-05-11","type":"pipeline","source":"Nature","summary":"Applications of synthetic biology in medical and pharmaceutical fields - Nature","headline":"Applications of synthetic biology in medical and pharmaceutical fields","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNWXFzdlMtM1VMZjVkNHNpNzc3WXhGeVNHRGcxWWljQVhDc2x1aW8zMG8zbDFDT1Y2UXVQbDhlRzNQd1BZWkhuaDZUbVUtSC1RRjRFOENpdGVIbURlek92NkFoZ0g5dVhrMy03aEI1SEpfYXJHYUlPeDZfMjdYX1pJM3E3VEpqRml0dEtuUmllSEVwdHYzTGh4MFNqWnhvZw?oc=5","date":"2021-05-26","type":"pipeline","source":"Timmerman Report","summary":"11 Asian-American Executives Shaping the Future of Biopharma - Timmerman Report","headline":"11 Asian-American Executives Shaping the Future of Biopharma","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}